Literature DB >> 17450022

Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment.

Ronnie Fass1.   

Abstract

Relief of symptoms, both typical and atypical, is the mainstay of therapy for patients with gastroesophageal reflux disease (GERD); however, evaluation of GERD symptoms' response to treatment has been hampered by the lack of a questionnaire that meets all the criteria of an ideal evaluative GERD symptom assessment tool. These criteria are: sensitivity in GERD patients, covering all symptom dimensions (multidimensional construct), assessment of frequency and intensity of "typical" and "atypical" GERD symptoms, practical and economical, easy to understand, responsive over short time intervals, use as a patient self-assessment tool, amenable to daily use, psychometrically validated, and translation into many languages with cross-cultural adaptation. Thus far, 14 instruments have been developed to assess GERD symptoms and potentially can be used to evaluate treatment response during a therapeutic trial in GERD patients. However, comparison of the different evaluative tools is needed.

Entities:  

Mesh:

Year:  2007        PMID: 17450022     DOI: 10.1097/MCG.0b013e31802e849f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  18 in total

1.  The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease.

Authors:  Nisa Netinatsunton; Siriboon Attasaranya; Bancha Ovartlarnporn; Sulee Sangnil; Sopa Boonviriya; Teerha Piratvisuth
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

2.  Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage.

Authors:  Shotaro Enomoto; Masashi Oka; Hiroshi Ohata; Chizu Mukoubayashi; Mika Watanabe; Kosaku Moribata; Yosuke Muraki; Naoki Shingaki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Hideyuki Tamai; Mitsuhiro Fujishiro; Osamu Mohara; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2011-04-16

3.  Population-based assessment of heartburn in urban Black Americans.

Authors:  F K Friedenberg; K Makipour; A Palit; S Shah; V Vanar; J E Richter
Journal:  Dis Esophagus       Date:  2012-12-13       Impact factor: 3.429

4.  Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis.

Authors:  Hiroto Miwa; Michio Hongo; Motoyasu Kusano
Journal:  J Gastroenterol       Date:  2011-11-01       Impact factor: 7.527

5.  Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in Japan.

Authors:  Michio Hongo; Hiroto Miwa; Motoyasu Kusano
Journal:  J Gastroenterol       Date:  2010-11-17       Impact factor: 7.527

6.  Determinants of asthma morbidity in World Trade Center rescue and recovery workers.

Authors:  Kevin Y Xu; Emily Goodman; Ruchir Goswami; Michael Crane; Laura Crowley; Paula Busse; Craig L Katz; Steven Markowitz; Rafael E de la Hoz; Hannah T Jordan; Gwen Skloot; Juan P Wisnivesky
Journal:  Ann Allergy Asthma Immunol       Date:  2016-10-24       Impact factor: 6.347

7.  [Modern diagnostic tools for esophageal pathologies].

Authors:  A Kandulski; P Malfertheiner; J Weigt
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

Review 8.  The concept of complete remission of gastro-oesophageal reflux disease : comparative efficacy of pantoprazole and esomeprazole using the ReQuest questionnaire.

Authors:  Alan B R Thomson
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

9.  A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

Authors:  Kazunari Tominaga; Mototsugu Kato; Hiroshi Takeda; Yasuyuki Shimoyama; Eiji Umegaki; Ryuichi Iwakiri; Kenji Furuta; Koichi Sakurai; Takeo Odaka; Hiroaki Kusunoki; Akihito Nagahara; Katsuhiko Iwakiri; Takahisa Furuta; Kazunari Murakami; Hiroto Miwa; Yoshikazu Kinoshita; Ken Haruma; Shin'ichi Takahashi; Sumio Watanabe; Kazuhide Higuchi; Motoyasu Kusano; Kazuma Fujimoto; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2014-02-18       Impact factor: 7.527

10.  Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Authors:  I M Modlin; R H Hunt; P Malfertheiner; P Moayyedi; E M Quigley; G N J Tytgat; J Tack; R C Heading; G Holtman; S F Moss
Journal:  Digestion       Date:  2009-06-17       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.